Groups | Search | Server Info | Login | Register

Groups > talk.politics.drugs > #7396

AstraZeneca makes deal with White House to lower drug prices

Cross-posted to 6 groups.

Show all headers | View raw

AstraZeneca became the second drugmaker to enter a deal with the Trump 
administration to offer lower prices to Medicaid and to offer some of its 
drugs at a discount through TrumpRx, a government website to facilitate 
sales directly to consumers.

"In other words the lowest price anywhere in the world, that's what we 
get," President Trump said during an Oval Office press conference Friday. 
The centerpiece of the deal is most-favored-nation pricing for drugs sold 
to Medicaid. That would link Medicaid prices to the lower ones paid in 
other developed countries.

As part of the deal, AstraZeneca will also offer discounts of up to 80% 
off list prices on direct sales to consumers, according to a company 
statement. Its drugs include inhalers like Bevespi Aerosphere for people 
with COPD and Airsupra for people with asthma. AstraZeneca, based in the 
U.K., also said it would expand drug manufacturing and research in the 
U.S.

In return for these commitments, the drug company will get a three-year 
exemption from certain tariffs.

The White House unveiled its plan for TrumpRx and a similar deal with 
Pfizer on Sept. 30. The website will help patients access drugs at lower 
prices — bypassing health insurance.

TrumpRx is part of a broader initiative the administration says is aimed 
at bringing prices paid by Americans more in line with those paid in other 
developed countries.

The announcement follows an executive order in May, and letters to 17 
pharmaceutical companies sent out over the summer to push them to lower 
prices voluntarily.

The TrumpRx website is expected to launch sometime in 2026, and would take 
consumers to pharmaceutical companies' direct-to-consumer websites to 
fulfill orders.

The impact of the Trump administration deals with pharmaceutical companies 
for consumers is unclear. Medicaid and its beneficiaries, for instance, 
already pay some of the lowest prices for drugs. And people with health 
insurance could spend less on their medicines through copays than buying 
them directly from AstraZeneca.

AstraZeneca also said Thursday that it would invest an additional $500 
million in a new manufacturing facility in Virginia, raising the 
investment to $4.5 billion. That's part of a $50 billion investment 
announced in July to expand manufacturing facilities in California, 
Indiana, Maryland, Massachusetts, Texas and Virginia, as well as other 
research and development efforts.

"For all the pharmaceutical companies out there — we're talking to all of 
you, pick up a shovel," said Dr. Mehmet Oz, who leads the Centers for 
Medicare and Medicaid Services, during the press conference.

Trump said his administration had gotten a total of $18 trillion total 
commitments to re-shore pharmaceutical manufacturing. NPR wasn't 
immediately able to independently confirm that number.

https://www.npr.org/sections/shots-health-news/2025/10/10/nx-s1-
5571070/astrazeneca-trump-drug-prices

Back to talk.politics.drugs | Previous | Next | Find similar

Thread

AstraZeneca makes deal with White House to lower drug prices useapen <yourdime@outlook.com> - 2025-10-11 08:20 +0000

csiph-web